Chemical Structure (Jevtana 01)
Jevtana Kit
Product Images NDC 0024-5824
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Jevtana (NDC 0024-5824). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Jevtana 02)
Figure 2 (Jevtana 03)
Principal Display Panel (Kit Carton)
The text is describing a graph that shows the rPFS (months) using Kaplan-Meier curves, based on an ITT population that was treated with Cabazitaxel + Censored or Enzalutamide/Abiraterone. The graph shows the number at risk over time, which is displayed in months. There are no additional details available.*
Principal Display Panel (60 mg/1.5 mL Vial Label)
This is information related to the drug JEVTANA which is used for intravenous infusion only after proper dilution. It is a cytotoxic agent and its dosage is provided. The package contains two vials, one with the actual drug and the other with the diluent. The text also includes warnings and the components of the drug.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
